Celldex Therapeutics Company Profile (NASDAQ:CLDX)

About Celldex Therapeutics

Celldex Therapeutics logoCelldex Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other diseases. Its lead drug Rintega (rindopepimut and CDX-110) is a therapeutic vaccine in clinical studies for the treatment of glioblastoma patients that express a specific cancer marker known as type III epidermal growth factor receptor mutation (EGFRvIII). Its Glembatumumab vedotin (CDX-011) is a targeted antibody-drug conjugate for the treatment of metastatic melanoma. Its Varlilumab (CDX-1127) is an immune modulating antibody that is designed to enhance a patient's immune response against their cancer. Its earlier stage drug candidates in clinical development include CDX-1401, which is a targeted immunotherapeutic aimed at antigen presenting cells (APC) for cancer indications and CDX-301, which is an immune cell mobilizing agent and dendritic cell growth factor.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: CLDX
  • CUSIP: 15117B10
Key Metrics:
  • Previous Close: $3.80
  • 50 Day Moving Average: $3.77
  • 200 Day Moving Average: $4.13
  • 52-Week Range: $2.96 - $18.62
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.34
  • P/E Growth: 0.00
  • Market Cap: $406.20M
  • Outstanding Shares: 100,545,000
  • Beta: 3.26
Profitability:
  • Net Margins: -2,383.60%
  • Return on Equity: -47.59%
  • Return on Assets: -41.57%
Debt:
  • Current Ratio: 11.44%
  • Quick Ratio: 11.44%
Additional Links:
Companies Related to Celldex Therapeutics:

Analyst Ratings

Consensus Ratings for Celldex Therapeutics (NASDAQ:CLDX) (?)
Ratings Breakdown: 5 Hold Ratings, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $10.75 (166.09% upside)

Analysts' Ratings History for Celldex Therapeutics (NASDAQ:CLDX)
Show:
DateFirmActionRatingPrice TargetDetails
8/11/2016Jefferies GroupReiterated RatingHold$4.00 -> $5.00View Rating Details
8/9/2016WedbushReiterated RatingNeutral$3.00View Rating Details
6/7/2016Cowen and CompanyReiterated RatingOutperform$12.00View Rating Details
4/19/2016Roth CapitalReiterated RatingBuy$7.00View Rating Details
3/8/2016Brean CapitalReiterated RatingBuy$24.00View Rating Details
3/8/2016HC WainwrightLower Price TargetBuy$25.00 -> $6.00View Rating Details
3/7/2016Leerink SwannDowngradeOutperform -> Market Perform$30.00 -> $4.00View Rating Details
3/7/2016Oppenheimer Holdings Inc.DowngradeOutperform -> Market PerformView Rating Details
3/7/2016GuggenheimDowngradeBuy -> NeutralView Rating Details
2/26/2016Cantor FitzgeraldLower Price TargetBuy$31.00 -> $25.00View Rating Details
6/1/2015WBB SecuritiesReiterated RatingBuy$30.00 -> $40.00View Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for Celldex Therapeutics (NASDAQ:CLDX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/8/2016Q2($0.34)($0.32)$0.96 million$1.39 millionViewListenView Earnings Details
5/5/2016Q1 16($0.35)($0.35)$1.06 million$1.30 millionViewN/AView Earnings Details
2/25/2016Q415($0.35)($0.33)$0.80 million$1.80 millionViewListenView Earnings Details
11/5/2015Q3($0.35)($0.32)ViewN/AView Earnings Details
8/10/2015Q215($0.34)($0.33)$2.20 millionViewListenView Earnings Details
4/29/2015Q115($0.36)($0.33)$0.52 million$0.49 millionViewN/AView Earnings Details
2/24/2015Q314($0.35)($0.36)$0.49 million$1.50 millionViewN/AView Earnings Details
11/5/2014Q3($0.31)($0.31)$0.43 million$1.10 millionViewN/AView Earnings Details
8/6/2014Q214($0.32)($0.32)$0.38 million$0.60 millionViewN/AView Earnings Details
5/1/2014($0.25)($0.33)$0.34 million$0.40 millionViewN/AView Earnings Details
3/3/2014Q413($0.28)($0.27)$0.27 million$0.62 millionViewN/AView Earnings Details
11/5/2013Q313($0.24)($0.29)$0.09 million$1.00 millionViewN/AView Earnings Details
8/6/2013Q2 2013($0.22)($0.24)$1.57 million$0.97 millionViewN/AView Earnings Details
5/2/2013Q1 2013($0.22)($0.23)$2.65 million$2.41 millionViewN/AView Earnings Details
3/7/2013Q4 2012($0.25)($0.27)$2.45 million$3.65 millionViewN/AView Earnings Details
11/1/2012Q312($0.24)($0.25)$2.07 million$3.11 millionViewN/AView Earnings Details
8/10/2012($0.25)($0.23)ViewN/AView Earnings Details
5/3/2012($0.25)($0.27)ViewN/AView Earnings Details
3/7/2012($0.26)($0.29)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Celldex Therapeutics (NASDAQ:CLDX)
Current Year EPS Consensus Estimate: $-1.34 EPS
Next Year EPS Consensus Estimate: $-1.21 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20166($0.39)($0.34)($0.36)
Q2 20167($0.39)($0.29)($0.34)
Q3 20166($0.38)($0.27)($0.32)
Q4 20167($0.39)($0.20)($0.32)
Q1 20171($0.34)($0.34)($0.34)
Q3 20171($0.24)($0.24)($0.24)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Celldex Therapeutics (NASDAQ:CLDX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Celldex Therapeutics (NASDAQ:CLDX)
Insider Ownership Percentage: 4.20%
Institutional Ownership Percentage: 78.41%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/2/2016Tibor KelerVPBuy3,000$3.32$9,960.00View SEC Filing  
11/23/2015Avery W. CatlinCFOSell25,000$18.00$450,000.00View SEC Filing  
8/25/2015Larry EllbergerDirectorBuy5,000$14.00$70,000.00View SEC Filing  
8/20/2015Larry EllbergerDirectorBuy5,000$15.00$75,000.00View SEC Filing  
8/18/2015Larry EllbergerDirectorBuy5,000$15.95$79,750.00View SEC Filing  
8/13/2015Anthony S MarucciCEOBuy5,800$16.81$97,498.00View SEC Filing  
8/13/2015Larry EllbergerDirectorBuy5,000$16.59$82,950.00View SEC Filing  
6/15/2015Avery W CatlinCFOSell25,000$24.59$614,750.00View SEC Filing  
12/6/2013Avery CatlinCFOSell183,333$24.50$4,491,658.50View SEC Filing  
12/6/2013Larry EllbergerDirectorSell17,728$24.50$434,336.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Celldex Therapeutics (NASDAQ:CLDX)
DateHeadline
capitalcube.com logoETF’s with exposure to Celldex Therapeutics, Inc. : September 30, 2016 (NASDAQ:CLDX)
www.capitalcube.com - September 30 at 4:40 PM
News IconActive biotech company shares in the news: Celldex Therapeutics, Inc. (NASDAQ:CLDX), Celgene Corporation ... - The Voice Registrar (NASDAQ:CLDX)
voiceregistrar.com - September 30 at 9:17 AM
News IconBiotech Stocks Worth Chasing: MannKind Corp. (MNKD), Celldex Therapeutics, Inc. (CLDX) - The Independent Republic (NASDAQ:CLDX)
theindependentrepublic.com - September 30 at 9:17 AM
capitalcube.com logoCelldex Therapeutics, Inc. – Value Analysis (NASDAQ:CLDX) : September 29, 2016 (NASDAQ:CLDX)
www.capitalcube.com - September 29 at 4:08 PM
News IconStock Buzz- Celldex Therapeutics, Inc. (NASDAQ:CLDX) - Hot Stocks Point (NASDAQ:CLDX)
www.hotstockspoint.com - September 28 at 4:08 PM
News IconHot Biotech Stocks Recap: Celldex Therapeutics, Inc. (NASDAQ:CLDX), Amgen Inc. (NASDAQ:AMGN) - The Voice Registrar (NASDAQ:CLDX)
voiceregistrar.com - September 28 at 4:08 PM
capitalcube.com logoCelldex Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CLDX-US : September 28, 2016 (NASDAQ:CLDX)
www.capitalcube.com - September 28 at 9:06 AM
fool.com logoWhy Celldex Therapeutics, Inc. Ran Higher Today (NASDAQ:CLDX)
www.fool.com - September 27 at 4:27 PM
News IconHC Stocks in Focus! Celldex Therapeutics, Inc. (CLDX), Northwest Biotherapeutics, Inc (NASDAQ:NWBO) - share market updates (press release) (NASDAQ:CLDX)
sharemarketupdates.com - September 26 at 4:29 PM
News IconToday's Chart On Watch: Celldex Therapeutics, Inc. Can't Be More Risky. The Stock Formed a Multiple Bottom Chart ... - Chester News (NASDAQ:CLDX)
www.chesterindependent.com - September 26 at 4:29 PM
4-traders.com logoCelldex Therapeutics : to Present at the Leerink Partners Rare Disease & Immuno-Oncology Roundtable (NASDAQ:CLDX)
www.4-traders.com - September 24 at 8:29 AM
News IconActive Biotech Stock News: Amicus Therapeutics, Inc. (FOLD ... - The Independent Republic (NASDAQ:CLDX)
theindependentrepublic.com - September 23 at 3:39 PM
publicnow.com logoCelldex Therapeutics to Present at the Leerink Partners Rare Disease & Immuno-Oncology Roundtable (NASDAQ:CLDX)
www.publicnow.com - September 23 at 3:39 PM
News IconEye-Catching Stock: Celldex Therapeutics, Inc. (NASDAQ:CLDX), Clean Energy Fuels Corp. (NASDAQ:CLNE) - Newburgh Press (NASDAQ:CLDX)
newburghpress.com - September 22 at 9:53 AM
News Icon2 Biotech Stocks News And Price Trends: Celldex Therapeutics, Inc. (NASDAQ:CLDX), Navidea Biopharmaceuticals ... - The Voice Registrar (NASDAQ:CLDX)
voiceregistrar.com - September 21 at 4:53 PM
News IconLong Term Growth review of Celldex Therapeutics (CLDX) - Newburgh Press (NASDAQ:CLDX)
newburghpress.com - September 21 at 8:17 AM
investopedia.com logoCelldex Therapeutics Remains a Guessing Game - Investopedia (NASDAQ:CLDX)
www.investopedia.com - September 21 at 8:17 AM
News IconAnalysts Valuations For Two Stocks: Celldex Therapeutics, Inc. (NASDAQ:CLDX), ZIOPHARM Oncology Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:CLDX)
voiceregistrar.com - September 21 at 8:17 AM
investopedia.com logoCelldex Therapeutics Remains a Guessing Game (NASDAQ:CLDX)
www.investopedia.com - September 21 at 8:17 AM
News IconNews review of 2 biotech stocks: Celldex Therapeutics, Inc. (NASDAQ:CLDX), Intrexon Corporation (NYSE:XON) - The Voice Registrar (NASDAQ:CLDX)
voiceregistrar.com - September 20 at 10:03 AM
News IconHC Stocks Vigilant! Catalent Inc (CTLT), Celldex Therapeutics, Inc. (NASDAQ:CLDX) - share market updates (press release) (NASDAQ:CLDX)
sharemarketupdates.com - September 19 at 8:58 AM
News IconActive biotech company shares in the news: Celldex Therapeutics, Inc. (NASDAQ:CLDX), Inovio Pharmaceuticals, Inc ... - The Voice Registrar (NASDAQ:CLDX)
voiceregistrar.com - September 16 at 4:09 PM
News IconCelldex Therapeutics, Inc. (NASDAQ:CLDX) Insider Trading Report - Newburg Press (NASDAQ:CLDX)
newburghpress.com - September 16 at 4:09 PM
News IconAnalysts Valuations For Two Stocks: Celldex Therapeutics, Inc. (NASDAQ:CLDX), Dunkin Brands Group Inc (NASDAQ ... - The Voice Registrar (NASDAQ:CLDX)
voiceregistrar.com - September 16 at 4:09 PM
News IconActive biotech company shares in the news: Celldex Therapeutics ... - The Voice Registrar (NASDAQ:CLDX)
voiceregistrar.com - September 15 at 4:36 PM
News IconIs A Celldex Therapeutics, Inc. (NASDAQ:CLDX) Short Squeeze On ... - Street Register (NASDAQ:CLDX)
streetregister.com - September 15 at 4:36 PM
News IconIs A Celldex Therapeutics, Inc. (NASDAQ:CLDX) Short Squeeze On The Cards? (NASDAQ:CLDX)
streetregister.com - September 15 at 10:52 AM
4-traders.com logoACADIA Pharmaceuticals : Biotech Stocks on Investors' Radar -- Eleven Biotherapeutics, CytRx, Celldex Therapeutics, and ACADIA Pharma (NASDAQ:CLDX)
www.4-traders.com - September 14 at 4:19 PM
247wallst.com logoKey FDA Decisions and Trial Results Coming in the Next 2 Months (NASDAQ:CLDX)
247wallst.com - September 14 at 8:30 AM
fool.com logoWhy Celldex Therapeutics, Inc. Stock Sank 28.1% in August -- The ... - Motley Fool (NASDAQ:CLDX)
www.fool.com - September 13 at 9:04 AM
capitalcube.com logoETF’s with exposure to Celldex Therapeutics, Inc. : September 12, 2016 (NASDAQ:CLDX)
www.capitalcube.com - September 12 at 4:05 PM
fool.com logoWhy Celldex Therapeutics, Inc. Stock Sank 28.1% in August (NASDAQ:CLDX)
www.fool.com - September 12 at 8:13 AM
News IconNews review of 2 biotech stocks: Celldex Therapeutics, Inc. (NASDAQ:CLDX), BioMarin Pharmaceutical Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:CLDX)
voiceregistrar.com - September 10 at 8:54 AM
News IconCelldex Therapeutics, Inc.'s (CLDX) (NASDAQ:CLDX)
10thousandcouples.com - September 9 at 9:03 AM
News IconBiotechnology Stocks under Discussion: ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC), Celldex Therapeutics ... - Post Registrar (NASDAQ:CLDX)
postregistrar.com - September 8 at 5:25 AM
News IconAnalysts Valuations For Two Stocks: Celldex Therapeutics (NASDAQ:CLDX), 3D Systems (NYSE:DDD) - The Voice Registrar (NASDAQ:CLDX)
voiceregistrar.com - September 7 at 8:21 AM
News IconTrading the Biotech News: Celldex Therapeutics, Inc. (NASDAQ:CLDX), Juno Therapeutics Inc. (NASDAQ:JUNO) - The Voice Registrar (NASDAQ:CLDX)
voiceregistrar.com - September 3 at 3:59 PM
News IconIntraday Active Biotech Stocks News: Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK), Celldex Therapeutics, Inc ... - The Voice Registrar (NASDAQ:CLDX)
voiceregistrar.com - August 29 at 3:38 PM
News IconAnalyst Outlook on Price Target: Celldex Therapeutics, Inc. (NASDAQ:CLDX) - Post Registrar (NASDAQ:CLDX)
postregistrar.com - August 29 at 3:38 PM
capitalcube.com logoETF’s with exposure to Celldex Therapeutics, Inc. : August 29, 2016 (NASDAQ:CLDX)
www.capitalcube.com - August 29 at 3:38 PM
fool.com logo3 Reasons Celldex Therapeutics, Inc. Stock Could Fall (NASDAQ:CLDX)
www.fool.com - August 27 at 8:58 AM
News IconAnalysts Valuations For Two Stocks: JetBlue Airways (NASDAQ:JBLU), Celldex Therapeutics (NASDAQ:CLDX) - The Voice Registrar (NASDAQ:CLDX)
voiceregistrar.com - August 23 at 8:27 AM
News IconWatch List: Abbott Laboratories (NYSE:ABT), Celldex Therapeutics, Inc. (NASDAQ:CLDX) - Post Registrar (NASDAQ:CLDX)
postregistrar.com - August 22 at 4:21 PM
capitalcube.com logoETF’s with exposure to Celldex Therapeutics, Inc. : August 18, 2016 (NASDAQ:CLDX)
www.capitalcube.com - August 18 at 9:32 PM
News IconBiotech news that matter for investors: Celldex Therapeutics (NASDAQ:CLDX), TetraLogic Pharmaceuticals (NASDAQ ... - The Voice Registrar (NASDAQ:CLDX)
voiceregistrar.com - August 17 at 10:59 AM
News IconBiotech Industry on the Upswing after Rocky Start to 2016 (NASDAQ:CLDX)
news.investornetwork.com - August 17 at 10:59 AM
capitalcube.com logoCelldex Therapeutics, Inc. :CLDX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016 (NASDAQ:CLDX)
www.capitalcube.com - August 16 at 4:19 PM
finance.yahoo.com logoCELLDEX THERAPEUTICS, INC. Financials (NASDAQ:CLDX)
finance.yahoo.com - August 16 at 4:19 PM
fool.com logoHow Risky Is Celldex Therapeutics, Inc.? (NASDAQ:CLDX)
www.fool.com - August 12 at 2:18 PM
smarteranalyst.com logoCompany Update (NASDAQ:CLDX): Celldex Therapeutics, Inc. Names Elizabeth Crowley as Chief Product ... - Smarter Analyst (NASDAQ:CLDX)
www.smarteranalyst.com - August 12 at 11:48 AM

Social

Celldex Therapeutics (NASDAQ:CLDX) Chart for Saturday, October, 1, 2016


Last Updated on 10/1/2016 by MarketBeat.com Staff